Silence Therapeutics Plc (SLNCF)
4.00
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Silence Therapeutics EPS Diluted (Quarterly) : -0.0866 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0866 |
| March 31, 2026 | -0.1055 |
| December 31, 2025 | -0.0831 |
| September 30, 2025 | -0.1479 |
| June 30, 2025 | -0.193 |
| March 31, 2025 | -0.2014 |
| September 30, 2024 | -0.2487 |
| June 30, 2024 | -0.14 |
| March 31, 2024 | -0.0175 |
| Date | Value |
|---|---|
| December 31, 2023 | -0.1504 |
| September 30, 2023 | -0.0933 |
| June 30, 2023 | -0.12 |
| March 31, 2023 | -0.1149 |
| December 31, 2022 | -0.1497 |
| September 30, 2022 | -0.0846 |
| June 30, 2022 | -0.1668 |
| March 31, 2022 | -0.1148 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.007 |
| Mereo BioPharma Group Plc | -0.0437 |
| Compass Pathways Plc | -1.883 |
| HemoGenyx Pharmaceuticals Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.27M |
| Total Expenses (Quarterly) | 12.27M |
| Enterprise Value | 495.01M |
| Earnings Yield | -10.58% |
| Normalized Earnings Yield | -10.58 |